Ptc Therapeutics, Inc. · NASDAQ:PTCT

Almstead Neil Gregory sold 46,774 Ptc Therapeutics, Inc. shares (Form 4)

Traded Jul 6 to Jul 7, 2026 · Filed Jul 8, 2026

From Jul 6 to Jul 7, 2026, Almstead Neil Gregory (CHIEF TECHNICAL OPS OFFICER) sold 46,774 Ptc Therapeutics, Inc. shares at an average US$87.52 for US$4.09M under a trading plan, leaving 60,299 shares. Filed Jul 8, 2026 (Form 4).

Sold
46,774 shares
Price
US$87.52 average (US$85.28 to US$89.44)
Value
US$4.09M
Holding after
60,299 shares
Trading plan
Yes (Made under a plan set in advance)
Role
CHIEF TECHNICAL OPS OFFICER

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jul 6, 2026Common StockOption exercise811US$38.1061,110Direct
Jul 6, 2026Common StockSale426US$85.2860,684Direct
Jul 6, 2026Common StockSale385US$86.3460,299Direct
Jul 6, 2026Common StockOption exercise18,876US$38.1079,175Direct
Jul 6, 2026Common StockSale8,786US$85.3570,389Direct
Jul 6, 2026Common StockSale10,090US$86.3260,299Direct
Jul 6, 2026Common StockOption exercise2,474US$39.4262,773Direct
Jul 6, 2026Common StockSale2,474US$87.0360,299Direct
Jul 7, 2026Common StockOption exercise24,613US$39.4284,912Direct
Jul 7, 2026Common StockSale3,956US$87.1780,956Direct
Jul 7, 2026Common StockSale11,369US$89.0369,587Direct
Jul 7, 2026Common StockSale9,288US$89.4460,299Direct

Source

View original at SEC

Related